Enter the passphrase to be encrypted.
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with SHA1:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with SHA224:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with SHA256:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with SHA384:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with SHA512:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with RIPEMD128:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with RIPEMD160:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with RIPEMD256:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with RIPEMD320:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with WHIRLPOOL:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with TIGER128,3:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with TIGER160,3:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with TIGER192,3:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with TIGER128,4:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with TIGER160,4:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with TIGER192,4:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with SNEFRU:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with SNEFRU256:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with GOST:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with GOST-CRYPTO:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with ADLER32:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with CRC32:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with CRC32B:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with FNV132:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with FNV1A32:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with FNV164:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with FNV1A64:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with JOAAT:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with HAVAL128,3:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with HAVAL160,3:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with HAVAL192,3:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with HAVAL224,3:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with HAVAL256,3:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with HAVAL128,4:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with HAVAL160,4:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with HAVAL192,4:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with HAVAL224,4:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with HAVAL256,4:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with HAVAL128,5:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with HAVAL160,5:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with HAVAL192,5:
Encrypting Possible major, moderate, and minor d/d interactions noted during drug review. with HAVAL224,5: